Competitive disruption from organized chains entering radiology
Large pathology chains are venturing into advanced radiology, potentially increasing competition in core and new markets.
medium · analyst_questionVijaya Diagnostic Centre Limited — Q3 FY26
Vijaya Diagnostic delivered a record quarter with revenue of ₹205 crore (+21.4% YoY) and EBITDA margin expansion of 221 bps to 41.9%, driven by strong volume growth of 14.7% and...
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Realization dilution from pathology mix shift
As new hubs stabilize, higher pathology share could reduce revenue per test, though tariff hikes may offset.
low · analyst_questionCurrency and GST impact on capex
USD/INR volatility and GST changes could affect equipment costs, though management expects minimal net impact.
low · analyst_questionExecution risk in new geography expansion
Rapid hub and spoke expansion in West Bengal, Bangalore, and Pune may strain operational bandwidth and delay stabilization.
medium · data_observation